CHCCX
Price
$4.06
Change
-$0.01 (-0.25%)
Updated
Sep 20 closing price
RPTIX
Price
$109.40
Change
-$0.77 (-0.70%)
Updated
Sep 20 closing price
Ad is loading...

CHCCX vs RPTIX

Header iconCHCCX vs RPTIX Comparison
Open Charts CHCCX vs RPTIXBanner chart's image
AB Discovery Growth C
Price$4.06
Change-$0.01 (-0.25%)
VolumeN/A
CapitalizationN/A
T. Rowe Price Mid-Cap Growth I
Price$109.40
Change-$0.77 (-0.70%)
VolumeN/A
CapitalizationN/A
View a ticker or compare two or three
CHCCX vs RPTIX Comparison Chart
Loading...
VS
CHCCX vs. RPTIX commentary
Sep 21, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CHCCX is a StrongBuy and RPTIX is a StrongBuy.

FUNDAMENTALS
Fundamentals
RPTIX has more cash in the bank: 31.4B vs. CHCCX (2.81B). RPTIX pays higher dividends than CHCCX: RPTIX (0.18) vs CHCCX (0.00). CHCCX was incepted earlier than RPTIX: CHCCX (31 years) vs RPTIX (9 years). CHCCX is a more actively managed with annual turnover of: 70.00 vs. RPTIX (21.70). CHCCX has a lower initial minimum investment than RPTIX: CHCCX (2500) vs RPTIX (500000). CHCCX annual gain was more profitable for investors over the last year : 30.13 vs. RPTIX (14.81). RPTIX return over 5 years is better than : 15.09 vs. CHCCX (-33.22).
CHCCXRPTIXCHCCX / RPTIX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence31 years9 years-
Gain YTD15.3419.127168%
Front LoadN/AN/A-
Min. Initial Investment25005000001%
Min. Initial Investment IRAN/AN/A-
Net Assets2.81B31.4B9%
Annual Yield % from dividends0.000.18-
Returns for 1 year30.1314.81203%
Returns for 3 years-42.00-13.57309%
Returns for 5 years-33.2215.09-220%
Returns for 10 years-40.03N/A-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CLH246.88-0.54
-0.22%
Clean Harbors
TOI0.29N/A
-0.58%
Oncology Institute (The)
CINT6.59-0.04
-0.60%
CI&T
CSTM16.22-0.54
-3.22%
Constellium SE
KTTA4.43-0.37
-7.71%
Pasithea Therapeutics Corp